Choose Your language:
- Testemunhos
-
Olá.
Gostaria de agradecer o rápido e eficiente serviço. Os comprimidos chegaram dentro do prazo.. Recomendei o vosso sítio, não sei dizer se os comprimidos já foram usados.
Um grande abraço... e um feliz dia de São Patrício, do Irlandês em França.. - Kieran
Mais »
Nossa página de faturamento é certificada por:
- Novidades
-
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
- In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth
- Sildenafil citrate and pulmonary arterial hypertension
- Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure
- Fruit and vegetables do not reduce overall cancer risk, review concludes
- Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people
- Common painkillers could be linked to male reproductive disorder
- The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study
-
- New azithromycin study is no way to judge antibiotic's heart risk - MedCity News
- IBNLive
- Zithromax (Azithromycin): FDA Statement on Risk of Cardiovascular Death - Bay Net
- Bay NetZithromax (Azithromycin): FDA Statement on Risk of Cardiovascular DeathBay NetFDA is reviewing the results from this study and will communicate any new information on azithromycin and this study or the potential risk of QT interval prolongation after the agency has completed its review
- FDA to Review CV Risk With Azithromycin - Medscape
- FDA to Review CV Risk With AzithromycinMedscapeMay 17, 2012 — The US Food and Drug Administration (FDA) will review a new study showing that patients taking azithromycin (Zithromax, Pfizer) face a small increased risk for sudden cardiac death compared with patients taking amoxicillin
- Antibiotic death risk#nl#A com... - Dentistry IQ
- Antibiotic death risk#nl#A com
- Zithromax, Widely Used Antibiotic Known As Z-Pak, Linked With Rare But Deadly ... - Huffington Post
- CBC